Axway Joins MIT Center for Information Systems Research as a Patron, Helps Drive Evidenced-based Digital Transformation
Global API Management leader Axway (Euronext: AXW.PA) is now a patron of the MIT Center for Information Systems Research (CISR) joining nine other global patrons to help power smarter digital transformation.
The MIT CISR provides academic research insights for business technology leaders. Its global research team studies high-performing companies and shares findings about digital transformation in working papers, monthly briefings, and events.
“MIT CISR studies how companies will thrive in the digital era. Each member of our research team is super passionate about their topic and using evidence-based methods to understand what works to create business value in areas including: business models, data monetization, employee experience, digital partnerships and pathways to transformation. This process yields objective research to help leaders drive for results,” said Peter Weill, MIT CISR Chairman and Senior Research Scientist. “Research Patrons like Axway help fund research and give us crucial feedback on our research agenda and findings,” Weill added.
“Our patronship of MIT CISR is proof of our ‘Open Everything’ motto: we’re contributing to extending the reach of high-quality research that makes the entire business ecosystem better,” said Axway CEO Patrick Donovan.
MIT CISR Chairman and Senior Research Scientist Peter Weill will be the featured speaker at the annual Axway Summit, where he will share insights on replatforming the enterprise to be future-ready.
Axway Summit, which takes place online, will also feature a Women in Tech panel, “Transformers or disruptors,” moderated by Ann Lloyd, Axway VP Customer Success & Experience, and featuring Chhavi Bhargava, Data Exchange Service Manager at Ford Motor Co., Fernanda Toscano, IT Senior Executive at HDI Insurance, and Susanne Schütz, Senior Vice President Customer & Business Intelligence at DB Schenker.
Register for the upcoming Axway Summit in your region:
About Axway
Axway gives heritage IT infrastructure new life, helping more than 11,000 customers digitally transform and drive growth. With the Amplify API Management Platform — the only open platform for managing and governing APIs across teams, the hybrid cloud, and third-party solutions — we help companies move forward faster, reach new markets, and create brilliant digital experiences. Our MFT and B2B integration solutions have been trusted for 20 years. Axway employs over 1,800 people in 18 countries. Learn more at axway.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210427006220/en/
Contact information
Media Contact
Noel May
Tel. (203) 645-9038
nmay@axway.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LambdaTest Launches Professional Services to Elevate Quality Engineering Excellence20.9.2024 18:00:00 EEST | Press release
LambdaTest, a leading cloud-based unified testing platform, officially introduced its Professional Services, designed to transform how organizations achieve quality engineering excellence. This service offers a comprehensive suite of end-to-end testing solutions, powered by AI-driven technology, ensuring maximum test coverage, optimized test scripts, and seamless framework migrations. The newly launched services address key challenges enterprises face today—enhancing testing efficiency, increasing coverage, and reducing bottlenecks in QA. LambdaTest Professional Services also offers tailored test suite development, ensuring that organizations can craft custom solutions suited to their specific needs, while ongoing efficiency maintenance ensures long-term performance and quality. With flexible pricing plans that scale as per business needs, LambdaTest’s Professional Services are built for agility, making it easier for businesses of any size to implement robust testing frameworks and sta
Alvaria’s Workforce Enterprise Suite Becomes Aspect20.9.2024 16:00:00 EEST | Press release
Alvaria, a pioneer in workforce management and contact center customer experience technology, servicing large global enterprises and rapidly growing consumer brands, announced the rebirth of Aspect in response to accelerated company growth and a demand for more complex tools to support hybrid, remote and in-person workforces. Aspect encapsulates Alvaria’s Enterprise Workforce Suite and will operate as an Alvaria-owned subsidiary. Aspect returns to the brand portfolio with a modern and innovative suite of products, including their new next-generation platform, WorkforceOS, powered by predictive analytics and a mission to humanize the service economy. Aspect has a rich history of innovation and leadership in the contact center space, having pioneered the world’s first Automatic Call Distribution (ACD) and the first Workforce Management Software for contact centers. Alvaria has named Darryl Kelly as Chief Executive Officer to steward this brand evolution. Kelly, an accomplished senior lea
Adtran’s Coherent 100ZR and FSP 3000 OLS to play key role in OIF’s ECOC open interoperability showcase20.9.2024 15:00:00 EEST | Press release
Adtran today announced its key role in the Optical Internetworking Forum’s (OIF) demonstration of open, multi-vendor networking at the European Conference on Optical Communication (ECOC) 2024. At the center of the showcase are Adtran’s Coherent 100ZR QSFP28 pluggable module and its FSP 3000 open optical line system (OLS), which enables the transport of a wide range of data rates, including 100ZR and 400Gbit/s OpenZR+, as featured in this demo. Incorporating 100Gbit/s to 800Gbit/s coherent pluggable transceivers and various OLS technologies from multiple vendors, the demo showcases advancements in open optical networking and innovative vendor-neutral solutions, highlighting the importance of testing multi-vendor interoperability. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240920990844/en/ Adtran’s central role in the OIF demo underlines its commitment to developing open solutions that seamlessly interoperate with other ve
Matchday Champions , a New Class of Mobile Football Game Now Available Worldwide; Kicks off With In-Game Event Hosted by Soccer Superstar Alexia Putellas and Mega Influencer Celine Dept20.9.2024 14:00:00 EEST | Press release
Matchday, the developer of innovative mobile games for football’s five billion fans, has debuted its newest title, Matchday Champions. Today, the game is in early access globally, and it is celebrating with the limited-time “Copa Alexia x Céline,” a one-of-a-kind in-game tournament hosted by Spanish football World Cup Champion Alexia Putellas, and the immensely popular Belgian influencer Celine Dept. Backed by Lionel Messi’s Play Time fund, Alexia Putellas, and other industry legends in sports and games, Matchday Champions is a one-of-its-kind experience. The game allows players to collect, craft and manage their own dream squad made up of both men's and women's players. It delivers the excitement of football using a cutting edge narrative creation engine, ensuring no two matches are ever the same. More than two million people have already pre-registered ahead of launch. Matchday Champions is now available in early access globally for iOS and Android phones. Players who download the ga
Neu-REFIX Beta glucan receives rare pediatric disease and orphan drug designations from the US FDA for treatment of Duchenne Muscular Dystrophy20.9.2024 11:12:00 EEST | Press release
Neu REFIX Beta glucan, made in Japan has received both Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (US FDA) for treatment of Duchenne muscular Dystrophy (DMD). These designations would help take the progress in pre-clinical and clinical studies conducted in Japan and India to clinical trials in the USA, for approval by FDA. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240920153092/en/ The parable of the lost sheep mirrors our journey to find a solution for Duchenne Muscular Dystrophy (DMD), a rare disease. Our global interdisciplinary team is fortunate to have been gifted with Neu REFIX, whose hidden potentials of beneficial immune modulation, we unravelled by extensive preclinical and clinical studies. This gives hope to DMD patients for its potentials in improving their quality of life by halting the disease progress. Like the shepherd when he fou
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom